NO893472L - Vaksine-polypeptider. - Google Patents

Vaksine-polypeptider.

Info

Publication number
NO893472L
NO893472L NO89893472A NO893472A NO893472L NO 893472 L NO893472 L NO 893472L NO 89893472 A NO89893472 A NO 89893472A NO 893472 A NO893472 A NO 893472A NO 893472 L NO893472 L NO 893472L
Authority
NO
Norway
Prior art keywords
vaccine
polypeptides
Prior art date
Application number
NO89893472A
Other languages
English (en)
Norwegian (no)
Other versions
NO893472D0 (no
Inventor
James Francis Young
Christopher S Jones
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of NO893472D0 publication Critical patent/NO893472D0/no
Publication of NO893472L publication Critical patent/NO893472L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/46—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterized by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO89893472A 1988-08-31 1989-08-30 Vaksine-polypeptider. NO893472L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23880388A 1988-08-31 1988-08-31
US38755889A 1989-07-28 1989-07-28

Publications (2)

Publication Number Publication Date
NO893472D0 NO893472D0 (no) 1989-08-30
NO893472L true NO893472L (no) 1990-03-01

Family

ID=26931978

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89893472A NO893472L (no) 1988-08-31 1989-08-30 Vaksine-polypeptider.

Country Status (9)

Country Link
EP (1) EP0366239A1 (de)
AU (1) AU640348B2 (de)
DK (1) DK428589A (de)
FI (1) FI894072A7 (de)
HU (1) HUT54732A (de)
IL (1) IL91456A0 (de)
NO (1) NO893472L (de)
NZ (1) NZ230459A (de)
PT (1) PT91601A (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766601A (en) * 1990-08-08 1998-06-16 University Of Massachusetts Medical Center Cross-reactive influenza a immunization
FR2692898B1 (fr) * 1992-06-30 1995-06-02 Centre Nat Rech Scient Procédé d'obtention de protéines membranaires, et utilisation de ces protéines dans un but de diagnostic ou de vaccination.
WO1994019013A1 (en) * 1993-02-19 1994-09-01 Smithkline Beecham Corporation Influenza vaccine compositions containing 3-o-deacylated monophosphoryl lipid a
US9119810B2 (en) * 2005-11-18 2015-09-01 Rutgers, The State University Of New Jersey Compositions and vaccines against influenza A and influenza B infections
EP3450454A1 (de) 2010-07-22 2019-03-06 John W. Schrader Kreutz-schutz gegen influenzavirusinfektion
EP3672629A1 (de) 2018-03-26 2020-07-01 Boehringer Ingelheim Animal Health USA Inc. Verfahren zur herstellung einer immunogenen zusammensetzung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2477417A1 (fr) * 1980-03-07 1981-09-11 Pasteur Institut Nouvelles fractions douees de proprietes antigeniques isolees de virus grippal, leur procede de preparation et leur application therapeutique en tant qu'agents vaccinants
AR241713A1 (es) * 1984-08-30 1992-11-30 Smithkline Beckman Corp Molecula de dna con una secuencia de bases que codifica la proteina c13 y preparacion de vacunas contra la gripe.

Also Published As

Publication number Publication date
FI894072A0 (fi) 1989-08-30
EP0366239A1 (de) 1990-05-02
AU640348B2 (en) 1993-08-26
NZ230459A (en) 1993-04-28
FI894072L (fi) 1990-03-01
PT91601A (pt) 1990-03-30
IL91456A0 (en) 1990-04-29
NO893472D0 (no) 1989-08-30
DK428589D0 (da) 1989-08-30
HUT54732A (en) 1991-03-28
FI894072A7 (fi) 1990-03-01
DK428589A (da) 1990-03-01
AU4022589A (en) 1990-03-08

Similar Documents

Publication Publication Date Title
DE58905119D1 (de) Heteroaryloxyessigsaeure-n-isopropylanilide.
NO891568D0 (no) Proevebeholder.
FI880043A0 (fi) Lastenhet.
DE68921898D1 (de) Ringbinder.
NO891139D0 (no) Strekkstagskjoet.
DE68903708D1 (de) Spielkasten.
DE68909215D1 (de) Laseroszillator.
DE68901775D1 (de) Mammographiegeraet.
NO893472D0 (no) Vaksine-polypeptider.
NO895208D0 (no) Fluidsepareringsapparat.
FI895126A0 (fi) Snabbhaerdande neutrala silikontaetningsmedel.
FI83400B (fi) Faestningsklaemma.
FI895705A0 (fi) Hydrodynamisk koppling.
FI880046A0 (fi) Tryckdifferensmaetare.
FI895533A0 (fi) Precisionsmotstaondstunnskikt.
DE68905196D1 (de) Faschine.
ES1007733Y (es) Arqueta.
FI80861B (fi) Plastdosa.
DE68905146D1 (de) Indanderivate.
DE68904912D1 (de) Ringlaser-kreisel.
DE58908380D1 (de) Benzofuranylbiphenyle.
DE68905805D1 (de) Cyclopentano-vitamin d-analoge.
ES1005477Y (es) Braga-compresa.
ES1006297Y (es) Atadura-precinto.
ES1006543Y (es) Muneco equilibrista.